STOCK TITAN
  1. Home
  2. AMAG

AMAG (AMAG) Stock Price, News & Analysis

AMAG NASDAQ

Company Description

AMAG (NASDAQ: AMAG) is classified in the pharmaceuticals: major industry within the Health Technology sector.

This page collects what Stock Titan holds for AMAG, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
34.7M
Shares outstanding

Latest News

View All
—

Landsdowne Labs Names Bryan Laulicht CEO

—

Sensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent Director

management
—

AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)

—

Covis Group Completes Acquisition of AMAG Pharmaceuticals

acquisition
+1.41%

Covis Group S.à r.l. Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc.

+1.41%

AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients

AMAG has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. Key topics include management, acquisition, fda approval, conferences, earnings. View all AMAG news →

SEC Filings

View All

No SEC filings available for AMAG.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

AMAG Company Profile & Sector Positioning

AMAG (AMAG) operates in the Pharmaceuticals: Major industry within the broader Health Technology sector and is listed on the NASDAQ.